The MarketReader Minute
π Viking Therapeutics Partners with CordenPharma; Gilead, BioNTech, and Genmab See Mixed Market Reactions | Biotech Sector Insights
Key holdings within IBB have also faced losses, including Vertex Pharmaceuticals and Moderna, both of which contributed negatively to the ETF's performance.